Authors
Jiayi Ye, Yijun Zhao, Shuyang Mao, Xingxing Li, Zitong Wang, Xin Li, Xinchen Xu, Minqi Tao, Chunhai Xiao, Qingqing Huang, Gang Huang, Wei Xie
Published in
Cell communication and signaling : CCS. Jul 17, 2026. Epub Jul 17, 2026.
Abstract
The tumor microenvironment (TME) is a dynamic and constantly evolving milieu surrounding cancer cells, comprising numerous components that influence tumor growth. The Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEACAM) family has been found to be abnormally expressed in various cancers, and recent studies have highlighted its critical role in shaping and regulating the TME. Several antibody drugs targeting the CEACAM family have been developed over the last years. However, due to the physiological expression of CEACAMs in normal tissues, most of these targeted agents have yielded unsatisfactory clinical trial outcomes, characterized by significant toxicity and limited efficacy. In view of this, enhancing therapeutic efficacy while reducing adverse effects has become a focal point of current research. This review systematically summarizes the structural features of the CEACAM family and the intrinsic mechanistic differences underlying their tumor-promoting effects, and discusses the limitations of existing clinical drugs. Based on antibody optimization strategies, we propose a conceptual framework of "dual-recognition" antibodies and elaborate on precision targeting approaches at three levels-epitope, molecular, and environmental-to provide directional guidance for future investigations.
PMID:
42469792
Bibliographic data and abstract were imported from PubMed on 18 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0